Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.660
+0.110 (7.10%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $260.60 million as of April 17, 2025. Its market cap has decreased by -27.78% in one year.
Market Cap
260.60M
Enterprise Value
296.95M
1-Year Change
-27.78%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $260.60M, an increase of 109.64%. That is a compound annual growth rate of 18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 260.60M | -59.89% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |